HLL Lifecare IPO : Likely in next Financial Year

by khalid on 05/12/2010 · 0 comments

HLL Lifecare Limited was formerly known as Hindustan Latex Limited (HLL) and is a large contraceptives manufacturing company in Thiruvananthapuram, Kerala, India. The company is a state-owned contraceptives manufacturing company and the management plans to come up with an initial public offer (IPO) to raise funds in next fiscal. The company produce health care products, including condoms, blood bags, and contraceptive pills. One of HLL’s famous brand of contraceptive is Saheli, which is a oral contraceptive.

The Initial Public Offer (IPO) of HLL Lifecare Limited is likely to hit the market in next few months. The the company plans to invest Rs 570 crore in new projects such as setting up a ‘Vaccine Complex’ and ‘Medipark’. HLL Lifecare makes 130 crore unit of condoms under various brand names, including Moods, with a market share of 60-65 per cent in India. The company also exports condoms to over 100 countries outside India.

The Equity Shares are proposed to be listed on the Bombay Stock Exchange Limited (BSE) and the National Stock Exchange of India Limited (NSE).

Issue Detail:-
Issue Open : ——-–
Issue Type : 100% Book Built Issue IPO
Issue Size : Equity Shares of Rs 10 each
Issue Size : Rs. 570 Crores
Face Value : Rs 10 Per Equity Share
Issue Price : Rs. – Rs. Per Equity Share
Market Lot : Shares
Minimum Order Quantity : Shares
Listing At : BSE, NSE

The objects of the fresh issue :- The money raised from this IPO will be utilize by the company for new projects such as setting up a ‘Vaccine Complex’ and ‘Medipark’. The vaccine complex is being set up at Chingleput in Tamil Nadu,

Book Running Lead Managers (BRLMs) to the offer are Citigroup Global Markets India Private Limited and Edelweiss Capital Limited

Registrar of this issue is Karvy Computershare Private Limited Hyderabad .

Stay tuned to BelltheBull Blog for more on HLL Lifecare IPO !

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: